Description: SYNLAB AG provides clinical laboratory and medical diagnostic services for insurance companies, hospitals, pharmacies, national health organizations, practicing doctors, clinics, patients, governments, and corporations primarily in Europe. The company offers Coronavirus tests, and medical and veterinary diagnostics services. It operates through approximately 500 laboratories and 1,800 blood collection points in 36 countries in four continents. The company was founded in 1998 and is headquartered in Munich, Germany.
Home Page: www.synlab.com
Moosacher Straße 88
Munich,
80809
Germany
Phone:
49 89 307602 0
Officers
| Name | Title |
|---|---|
| Mr. Mathieu Floreani | Chief Exec. Officer |
| Dr. Bartholomäus Wimmer | Founder & Independent Member of the Supervisory Board |
| Mr. Sami Badarani | Chief Financial Officer |
| Mr. Robert Steinwander | Chief Operating Officer |
| Mr. Henrik Andreasen | Chief Information Officer |
| Fabian Walla | Group Gen. Counsel |
| Ms. Catharina Monster | Chief HR Officer |
| Mr. Luis Vieira | Chief Strategy Officer |
| Dr. Santiago Valor | Chief Medical Officer |
| Christoph Mahnke | CEO of SYNLAB Germany |
Exchange: XETRA
Country: DE
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 6.9935 |
| Price-to-Book MRQ: | 1.2475 |
| Price-to-Sales TTM: | 0.7281 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 25750 |